{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T18:17:51Z","timestamp":1774376271082,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Experimental Medicine Research Center, Tehran University of Medical Sciences"},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["96002757"],"award-info":[{"award-number":["96002757"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejphar.2018.01.025","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:22:09Z","timestamp":1517559729000},"page":"140-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Biphasic effect of sumatriptan on PTZ-induced seizures in mice: Modulation by 5-HT1B\/D receptors and NOS\/NO pathway"],"prefix":"10.1016","volume":"824","author":[{"given":"Maziar","family":"Gooshe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyvan","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mojtaba","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Tafakhori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayan","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vajiheh","family":"Aghamollaii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.01.025_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0301-0082(02)00077-1","article-title":"Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro","volume":"68","author":"Avoli","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1468-2982.2009.01864.x","article-title":"Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice","volume":"30","author":"Bates","year":"2010","journal-title":"Cephalalgia: Int. J. Headache"},{"key":"10.1016\/j.ejphar.2018.01.025_bib3","first-page":"107","article-title":"Abolition of seizure provoking effect of sumatriptan by fluoxetine in pentylenetetrazol induced seizures in rats","volume":"7","author":"Chavan","year":"2014","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/j.ejphar.2018.01.025_bib4","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/brain\/awq159","article-title":"Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers","volume":"133","author":"De Felice","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2018.01.025_bib5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/brain\/awq159","article-title":"Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers","volume":"133","author":"De Felice","year":"2010","journal-title":"Brain: A J. Neurol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.curtheres.2009.04.003","article-title":"The effect of sumatriptan on nitric oxide synthase enzyme production after iatrogenic inflammation in the brain stem of adolescent rats: a randomized, controlled, experimental study","volume":"70","author":"Demirpence","year":"2009","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.ejphar.2018.01.025_bib7","first-page":"8","article-title":"The role of the blood\u2013brain barrier in the development and treatment of migraine and other pain disorders","author":"DosSantos","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2018.01.025_bib8","first-page":"690","article-title":"Interaction between sample preparation techniques and three methods of nitrite determination","volume":"65","author":"Fox","year":"1982","journal-title":"J. - Assoc. Off. Anal. Chem."},{"key":"10.1016\/j.ejphar.2018.01.025_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0922-4106(89)90023-0","article-title":"NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices","volume":"172","author":"Garthwaite","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fneur.2014.00063","article-title":"Neuroactive peptides as putative mediators of antiepileptic ketogenic diets","volume":"5","author":"Giordano","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000116755","article-title":"Preclinical studies on the anti-migraine drug, sumatriptan","volume":"31","author":"Humphrey","year":"1991","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1046\/j.1526-4610.2002.02208.x","article-title":"Sumatriptan scavenges superoxide, hydroxyl, and nitric oxide radicals: in vitro electron spin resonance study","volume":"42","author":"Ikeda","year":"2002","journal-title":"Headache"},{"key":"10.1016\/j.ejphar.2018.01.025_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.47.4.1104","article-title":"Use of sumatriptan in post-ictal migraine headache","volume":"47","author":"Jacob","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2018.01.025_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0042-121419","article-title":"Sumatriptan, an Antimigraine Drug, Inhibits Pentylenetetrazol-induced Seizures in NMRI Mice","volume":"67","author":"Jand","year":"2017","journal-title":"Drug Res."},{"key":"10.1016\/j.ejphar.2018.01.025_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01151-7","article-title":"Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain","volume":"425","author":"Johnson","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/ene.12612","article-title":"The comorbid relationship between migraine and epilepsy: a systematic review and meta\u2010analysis","volume":"22","author":"Keezer","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0920-1211(91)90062-K","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models","volume":"8","author":"Loscher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2018.01.025_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"Loscher","year":"1988","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2018.01.025_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(10)70059-4","article-title":"Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders","volume":"9","author":"Mantegazza","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib20","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.01.025_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1468-2982.1999.019004223.x","article-title":"Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine","volume":"19","author":"O'quinn","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ejphar.2018.01.025_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0306-3623(96)00460-0","article-title":"5-HT1BD receptor antagonists","volume":"29","author":"Pauwels","year":"1997","journal-title":"Gen. Pharmacol.: Vasc. Syst."},{"key":"10.1016\/j.ejphar.2018.01.025_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2014.11.005","article-title":"Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2","volume":"57","author":"Payandemehr","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.01.025_bib24","first-page":"562","article-title":"GABA and glutamate in the human brain","volume":"8","author":"Petroff","year":"2002","journal-title":"Neurosci.: A Rev. J. Bringing Neurobiol. Neurol. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.01.025_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.33549\/physiolres.931903","article-title":"Serotonin receptors-from molecular biology to clinical applications","volume":"60","author":"Pytliak","year":"2011","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejphar.2018.01.025_bib26","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.bjp.0706027","article-title":"Postsynaptic 5-HT1B receptors modulate electroshock-induced generalised seizures in rats","volume":"144","author":"Stean","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.bjp.0706027","article-title":"Postsynaptic 5\u2010HT1B receptors modulate electroshock\u2010induced generalised seizures in rats","volume":"144","author":"Stean","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1468-2982.1999.1910859.x","article-title":"Serotonin 5HT1B\/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices","volume":"19","author":"Stepien","year":"1999","journal-title":"Cephalalgia: Int. J. Headache"},{"key":"10.1016\/j.ejphar.2018.01.025_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1468-2982.2003.00583.x","article-title":"5-HT(1B\/1D) serotonin receptor agonist attenuates nitroglycerin-evoked nitric oxide synthase expression in trigeminal pathway","volume":"23","author":"Suwattanasophon","year":"2003","journal-title":"Cephalalgia: Int. J. Headache"},{"key":"10.1016\/j.ejphar.2018.01.025_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.expneurol.2013.02.019","article-title":"The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains","volume":"247","author":"Watanabe","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib31","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1526-4610.2005.4501008.x","article-title":"Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention","volume":"45","author":"Welch","year":"2005","journal-title":"Headache.: J. Head Face Pain"},{"key":"10.1016\/j.ejphar.2018.01.025_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2006.04.049","article-title":"Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice","volume":"541","author":"Wesolowska","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.025_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2006.04.049","article-title":"Anticonvulsant effect of the selective 5-HT 1B receptor agonist CP 94253 in mice","volume":"541","author":"Weso\u0142owska","year":"2006","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:22:05Z","timestamp":1757974925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918300384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":33,"alternative-id":["S0014299918300384"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.025","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biphasic effect of sumatriptan on PTZ-induced seizures in mice: Modulation by 5-HT1B\/D receptors and NOS\/NO pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}